Lornoxicam



Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 33.8%
Rheumatoid Arthritis 18.1%
Suicide Attempt 6.6%
Bipolar Disorder 5.0%
Prophylaxis 4.7%
Analgesic Effect 3.8%
Cataract 3.8%
Breast Cancer Metastatic 3.1%
Lung Adenocarcinoma 2.8%
Analgesia 1.9%
Antibiotic Prophylaxis 1.9%
Gastritis 1.9%
Insomnia 1.9%
Osteoporosis 1.9%
Prophylaxis Against Gastrointestinal Ulcer 1.9%
Septic Shock 1.9%
Hypertension 1.6%
Epilepsy 1.3%
Neuralgia 1.3%
Premedication 1.3%
Gastric Ulcer Haemorrhage 13.8%
Pneumonitis Cryptococcal 13.8%
Neutrophil Count Decreased 6.9%
Renal Failure Acute 6.9%
Urinary Tract Infection 6.9%
Gastric Ulcer 3.4%
Large Intestine Perforation 3.4%
Melaena 3.4%
Pleural Effusion 3.4%
Pruritus 3.4%
Pyrexia 3.4%
Respiratory Depression 3.4%
Suicide Attempt 3.4%
Tachycardia 3.4%
Tachypnoea 3.4%
Tongue Oedema 3.4%
Vertigo 3.4%
Vomiting 3.4%
Vulval Oedema 3.4%
White Blood Cell Count Decreased 3.4%
Concomitant
Rheumatoid Arthritis 41.1%
Drug Use For Unknown Indication 8.8%
Osteoporosis 4.9%
Prophylaxis 4.6%
Product Used For Unknown Indication 4.2%
Crohn's Disease 4.0%
Gastritis Prophylaxis 3.9%
Hypertension 3.9%
Insomnia 3.9%
Cancer Pain 2.9%
Anaemia 2.5%
Pain 2.2%
Gastritis 1.9%
Constipation 1.7%
Depression 1.7%
Diabetes Mellitus 1.7%
Prophylaxis Against Gastrointestinal Ulcer 1.7%
Antibiotic Prophylaxis 1.5%
Ovarian Cancer 1.5%
Psoriatic Arthropathy 1.5%
Tachycardia 14.5%
Pneumonia 8.7%
Pyrexia 7.2%
Tongue Neoplasm Malignant Stage Unspecified 7.2%
Hepatic Neoplasm Malignant 5.8%
Pulmonary Embolism 5.8%
Swelling Face 5.8%
Interstitial Lung Disease 4.3%
Pneumonitis Cryptococcal 4.3%
Respiratory Tract Infection 4.3%
Swelling 4.3%
White Blood Cell Count Decreased 4.3%
Alveolitis Allergic 2.9%
Brain Stem Haemorrhage 2.9%
Cerebral Infarction 2.9%
Herpes Zoster 2.9%
Hypersensitivity 2.9%
Ischaemia 2.9%
Lung Disorder 2.9%
Miosis 2.9%
Interacting
Atrial Fibrillation 50.0%
Back Pain 50.0%
Peritonitis 100.0%